Tendon inflammation in children with juvenile arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at inflammation of the tendons (tenosynovitis) in children with juvenile idiopathic arthritis (JIA). It may help doctors better understand and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 16 years old when arthritis starts.
- Your child must have a diagnosis of juvenile idiopathic arthritis (a type of childhood arthritis).
- Your child's arthritis cannot be caused by another condition like injury, infection, cancer, or lupus.
- Your child cannot have had major surgery on the joints being examined.
- Your child cannot have an active infection or a metabolic disease affecting bones or muscles.
- You and your child must agree to take part in the study (informed consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain blood tests in children with juvenile idiopathic arthritis (JIA) to see if they can help measure how active the disease is. The goal is to find simpler ways to track arthritis activity and guide treatment.
This trial tests whether children with juvenile idiopathic arthritis (JIA) who have been doing well for over a year can safely reduce their medications. The goal is to find the best way to keep arthritis under control while avoiding unnecessary treatments.
This study looks at pain in kids with juvenile arthritis compared to healthy kids. It may help researchers understand pain better and improve future treatments.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This study looks at how oral health and mouth bacteria relate to disease activity in children with juvenile idiopathic arthritis (JIA). If your child has JIA, participating could help doctors understand more about the condition and may guide future treatments.
This study looks at immune cells in the blood of people with juvenile idiopathic arthritis (JIA) to see how different treatments affect them. It may help doctors understand the disease better and improve future care.
Hear when a new Juvenile Idiopathic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.